文献速递临床试验与 GCP流行病学与生物统计

多中心随机肿瘤试验中患者筛查日志的实施与效用

The implementation and utility of patient screening logs in a multicentre randomised controlled oncology trial.
PubMed 文献 · Trials · 2020-07-08

该研究回顾性探索性分析了一项上尿路尿路上皮癌化疗多中心随机对照试验中收集的筛查数据,评估筛查日志的效用及其对招募率的影响。结果显示,筛查日志可识别患者拒绝参与的原因并监测中心活动,但获取完整数据具有挑战性,且未发现集中收集筛查日志能提高招募率的证据。

要点

  • 筛查日志可识别患者拒绝试验的主要原因,如不愿接受化疗。
  • 筛查日志报告的患者数与招募数之间存在中等强度相关(r=0.47)。
  • 未发现集中收集筛查日志能改善招募率的证据,其持续使用需进一步研究。

核心结论

  • 集中收集筛查日志可识别患者拒绝参与的原因并帮助监测中心活动,但获取完整数据具有挑战性。
  • 筛查日志报告的患者数与招募数之间存在中等强度相关(r=0.47),但可能受中心可用患者人群混杂。
  • 未发现集中收集筛查日志能提高招募率的证据,其持续使用需进一步研究。

研究设计与样本

  • 对一项上尿路尿路上皮癌化疗多中心随机对照试验中收集的筛查数据进行回顾性探索性分析。
  • 参与中心维护符合试验方案基本筛查标准患者的记录,并定期提交至临床试验协调中心。
  • 数据收集于2012年5月至2016年8月,期间激活71个中心,招募期为2768个中心月。

主要发现

  • 筛查日志共报告1138例患者,协调中心发送2300次日志请求,收到预期日志的47%。
  • 758例患者被报告为不合格,36例合格患者未被接触,207例拒绝参与。
  • 接触率为91%(344/380),接受率为40%(137/344),这些比率在整个数据收集期间保持一致。
  • 患者拒绝的主要原因为不想接受化疗(99/207,48%)。
  • 筛查日志报告的患者数与每中心招募数之间存在中等强度相关(r=0.47)。

临床怎么用

  • 筛查日志可用于识别患者拒绝试验的原因并监测中心筛查活动。
  • 使用筛查日志需考虑相关工作负荷,并非适用于所有试验。
  • 不应期望通过集中收集筛查日志来提高招募率。

局限性

  • 获取完整筛查数据具有挑战性,仅收到预期日志的47%。
  • 筛查日志报告数与招募数的相关可能受中心可用患者人群混杂。
  • 28%的入组参与者未在日志中报告,数据完整性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The utility of patient screening logs and their impact on improving trial recruitment rates are unclear. We conducted a retrospective exploratory analysis of screening data collected within a multicentre randomised controlled trial investigating chemotherapy for upper tract urothelial carcinoma. METHODS: Participating centres maintained a record of patients meeting basic screening criteria stipulated in the trial protocol, submitting logs regularly to the clinical trial coordinating centre (CTC). Sites recorded the number of patients ineligible, not approached, declined and randomised. The CTC monitored proportions of eligible patients, approach rate (proportion of eligible patients approached) and acceptance rate (proportion recruited of those approached). Data were retrospectively analysed to identify patterns of screening activity and correlation with recruitment. RESULTS: Data were collected between May 2012 and August 2016, during which time 71 sites were activated-a recruitment period of 2768 centre months. A total of 1138 patients were reported on screening logs, with 2300 requests for logs sent by the CTC and 47% of expected logs received. A total of 758 patients were reported as ineligible, 36 eligible patients were not approached and 207 declined trial participation. The approach rate was 91% (344/380), and the acceptance rate was 40% (137/344); these rates remained consistent throughout the data collection. The main reason patients provided for declining (99/207, 48%) was not wanting to receive chemotherapy. There was a moderately strong correlation (r = 0.47) between the number reported on screening logs and the number recruited per site. Considerable variation in data between centres was observed, and 54/191 trial participants (28%) enrolled during this period were not reported on logs. CONCLUSIONS: Central collection of screening logs can identify reasons for patients declining trial participation and help monitor trial activity at sites; however, obtaining complete data can be challenging. There was a correlation between the number of patients reported on logs and recruitment; however, this was likely confounded by sites' available patient population. The use of screening logs may not be appropriate for all trials, and their use should be carefully considered in relation to the associated workload. No evidence was found that central collection of screening logs improved recruitment rates in this study, and their continued use warrants further investigation. TRIAL REGISTRATION: ISRCTN98387754 . Registered on 31 January 2012.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lewis R, Todd R, Newton M, et al. The implementation and utility of patient screening logs in a multicentre randomised controlled oncology trial. Trials. 2020. PMID: 32641097. doi:10.1186/s13063-020-04559-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。